Loan Payable and Warrant Liability - Textual (Details)				3 Months Ended	12 Months Ended
	Feb. 28, 2024 USD ($) shares	Mar. 10, 2023 USD ($) shares	Jun. 15, 2022 USD ($) Tranche	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares
Debt Instrument [Line Items]
Proceeds from term loan					$ 15,000,000	$ 10,000,000
Amortization of debt issuance costs and discount					$ 448,000	$ 204,000
Common stock, par value (in dollars per share) | $ / shares					$ 0.0001	$ 0.0001
Fair value change in warrant liability					$ 79,000	$ 264,000
Hercules
Debt Instrument [Line Items]
Issued warrants to purchase shares of common stock | shares		9,180
Loan Agreement
Debt Instrument [Line Items]
End of term charge of outstanding principal balance, in percentage			5.85%
Amortization of debt issuance costs and discount			$ 1,463,000
Issued warrants to purchase shares of common stock | shares					36,718
Recognized initial warrants at relative fair value					$ 227,000
Additional remaining warrants were recognized at relative fair value at closing of agreement					41,000
Fair value associated with equity and liability classified warrants					268,000
Warrant liabilities					54,000	$ 305,000
Fair value change in warrant liability					$ 79,000
Loan Agreement | First Twelve Months After Closing
Debt Instrument [Line Items]
Percentage of prepayment charge of outstanding principal balance			3.00%
Loan Agreement | Second Twelve Months After Closing
Debt Instrument [Line Items]
Percentage of prepayment charge of outstanding principal balance			2.00%
Loan Agreement | Thereafter
Debt Instrument [Line Items]
Percentage of prepayment charge of outstanding principal balance			1.00%
Loan Agreement | Hercules
Debt Instrument [Line Items]
Proceeds from term loan				$ 15,000,000
Loan Agreement | Term Loan | Hercules
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 100,000,000
Number of tranches available for loan | Tranche			4
Proceeds from term loan			$ 10,000,000
Term loan, description					Under the terms of the Loan Agreement, the Company received $10,000 upon closing, $15,000 was borrowed in March of 2023 and $30,000 remains available to the Company to borrow at its sole discretion until March 15, 2024. An additional $45,000 may become available to the Company at Hercules' sole discretion.
Maturity date			Jan. 01, 2027
Variable annual rate			7.65%
Loan Agreement | Term Loan | Hercules | Subsequent Event
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 150,000,000
Proceeds from term loan	$ 10,000,000
Issued warrants to purchase shares of common stock | shares	18,359
Loan Agreement | Term Loan | Hercules | Prime Rate
Debt Instrument [Line Items]
Variable annual rate			3.65%
Loan Agreement | Term Loan First Tranche
Debt Instrument [Line Items]
Remaining borrowing capacity					$ 10,000,000
Additional loan advances available					$ 10,000,000
Loan Agreement | Term Loan First Tranche | Hercules
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 45,000,000
Remaining borrowing capacity			30,000,000
Proceeds from term loan		$ 15,000,000	15,000,000
Additional loan advances available			$ 30,000,000
Warrants to Purchase Common Stock | Loan Agreement | Term Loan | Hercules
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares					$ 0.0001
Maximum percentage of warrants purchased					1.50%